Bringing the fundamentals into focus…
Back to Pacific Biosciences of California, Inc.
How Pacific Biosciences of California, Inc. stacks up
PACB · against 438 other Healthcare companies of similar size
Growth
44/ 100
Above the middle of the pack.
Ranked #216 of 439 · scores higher than 50% of peers
Bars: peers in each 10-point band of the growth score34 peers with a growth score of 40–49, including PACB · Click a bar to see the companies
Why growth scores 44?
Weighted metrics compared with all Healthcare companies.Its metrics sit close to the Healthcare norm.
- slower revenue growth over the last year: weaker than 64% of peers. Revenue growth: 2.0% vs peer median 6.1%
- slower revenue growth over three years: weaker than 62% of peers. 3-year revenue growth: 2.9% vs peer median 5.8%
- Still loss-making, but the loss per share narrowed. Earnings per share growth: — vs peer median 9.8%
Metric by metric
Position: dot = PACB, ranked from the worst peer (left) to the best (right); tick = middle, shaded = middle half of peers.| Metric | PACB | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Revenue growthHigher is better · 449 reported | 2.0% | 3.4% | 43% | 33% | |
| Earnings per share growthHigher is better · 241 reported | Not reported | 3.9% | — | — | 33% |
| 3-year revenue growthHigher is better · 432 reported | 2.9% | 4.5% | 44% | 33% |
A metric that is not reported is left out of the score; the other weights are rescaled.
Ranking by growth score
Top 5 and the companies ranked around PACB| Rank | Company | Market cap | Growth | Overall |
|---|---|---|---|---|
| 1 | 464M USD | 100 | 53 | |
| 2 | 8.9B HKD (≈$1.1B) | 99 | 61 | |
| 2 | 1.4B USD | 99 | 73 | |
| 2 | 433M USD | 99 | 81 | |
| 2 | 885M USD | 99 | 33 | |
| 214 | 133.4B JPY (≈$907M) | 45 | 53 | |
| 216 | 141.7B JPY (≈$963M) | 44 | 68 | |
| 216 | 63.7B INR (≈$764M) | 44 | 66 | |
| 216 | 862M AUD (≈$569M) | 44 | 54 | |
| 216 | 758M USD | 44 | 35 | |
| 220 | 3.5B CNY (≈$496M) | 43 | 38 | |
| 221 | 3.9B CNY (≈$543M) | 42 | 48 | |
| 221 | 7.2B CNY (≈$1.0B) | 42 | 62 | |
| 221 | 109.3B JPY (≈$743M) | 42 | 76 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score